USP17L10: A Drug Target / Disease Biomarker (G100287144)
USP17L10: A Drug Target / Disease Biomarker
USP17L10 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a member of the USP family of proteins, which are involved in the regulation of cell survival and growth. USP17L10 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, USP17L10 has become a focus of interest for researchers studying these conditions, and it may also be a potential drug target or biomarker.
The USP17L10 protein is composed of 114 amino acid residues and has a calculated molecular mass of 18.1 kDa. It is expressed in a variety of tissues, including the brain, heart, liver, and kidney, and has been shown to be involved in the regulation of cell survival and growth. For example, studies have shown that USP17L10 is involved in the development and progression of cancer, neurodegenerative diseases, and autoimmune disorders.
One of the most significant functions of USP17L10 is its role in the regulation of cell death. USP17L10 has been shown to play a role in the production of reactive oxygen species (ROS), which can damage cellular components and contribute to the development of various diseases. ROS can cause damage to cells byoxidizing oxygen, which can lead to the formation of reactive oxygen species. These reactive oxygen species can damage cellular components, including DNA, RNA, and proteins, and can lead to the development of a variety of diseases, including cancer and neurodegenerative diseases.
In addition to its role in cell death, USP17L10 is also involved in the regulation of cell growth. Studies have shown that USP17L10 plays a role in the regulation of cell proliferation, and that it is involved in the production of cell cycle-related proteins. USP17L10 has been shown to promote the growth of cancer cells and to inhibit the growth of healthy cells. This may contribute to its role in the development and progression of cancer.
Another function of USP17L10 is its role in the regulation of inflammation. Studies have shown that USP17L10 is involved in the production of pro-inflammatory cytokines, which can contribute to the development of inflammatory diseases. USP17L10 has been shown to promote the production of these cytokines and to contribute to the development of various inflammatory diseases, including autoimmune disorders.
In conclusion, USP17L10 is a protein that is involved in the regulation of cell death, growth, and inflammation. Its role in these processes makes it a potential drug target or biomarker for a variety of diseases. Further research is needed to fully understand the functions of USP17L10 and its potential as a drug.
Protein Name: Ubiquitin Specific Peptidase 17 Like Family Member 10
Functions: Deubiquitinating enzyme that removes conjugated ubiquitin from specific proteins to regulate different cellular processes that may include cell proliferation, progression through the cell cycle, apoptosis, cell migration, and the cellular response to viral infection
The "USP17L10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about USP17L10 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
USP17L11 | USP17L12 | USP17L13 | USP17L14P | USP17L15 | USP17L17 | USP17L18 | USP17L2 | USP17L20 | USP17L21 | USP17L24 | USP17L25 | USP17L26 | USP17L27 | USP17L29 | USP17L3 | USP17L5 | USP17L6P | USP17L7 | USP17L8 | USP17L9P | USP18 | USP19 | USP2 | USP2-AS1 | USP20 | USP21 | USP22 | USP24 | USP25 | USP26 | USP27X | USP27X-DT | USP28 | USP29 | USP3 | USP3-AS1 | USP30 | USP30-AS1 | USP31 | USP32 | USP32P1 | USP32P2 | USP32P3 | USP33 | USP34 | USP35 | USP36 | USP37 | USP38 | USP39 | USP4 | USP40 | USP41 | USP42 | USP43 | USP44 | USP45 | USP46 | USP46-DT | USP47 | USP48 | USP49 | USP5 | USP50 | USP51 | USP53 | USP54 | USP6 | USP6NL | USP6NL intronic transcript 1 (non-protein coding), transcript variant 1 | USP7 | USP8 | USP8P1 | USP9X | USP9Y | USPL1 | UST | UTF1 | UTP11 | UTP14A | UTP14C | UTP15 | UTP18 | UTP20 | UTP23 | UTP25 | UTP3 | UTP4 | UTP6 | UTRN | UTS2 | UTS2B | UTS2R | UTY | UVRAG | UVSSA | UXS1 | UXT | UXT-AS1
